NASDAQ

Legend Biotech Corporation - American Depositary Shares (LEGN)

637 Thanks from members

Legend Biotech (LEGN) displays a stark divergence between Wall Street's strong buy consensus and cautious retail sentiment, buoyed by a Q2 profitability milestone driven by CARVYKTI sales growth and an evolving pipeline.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →